Cargando…
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262813/ https://www.ncbi.nlm.nih.gov/pubmed/34233875 http://dx.doi.org/10.1126/sciadv.abf4408 |
_version_ | 1783719254065938432 |
---|---|
author | Berthelet, Jean Wimmer, Verena C. Whitfield, Holly J. Serrano, Antonin Boudier, Thomas Mangiola, Stefano Merdas, Michal El-Saafin, Farrah Baloyan, David Wilcox, Jordan Wilcox, Steven Parslow, Adam C. Papenfuss, Anthony T. Yeo, Belinda Ernst, Matthias Pal, Bhupinder Anderson, Robin L. Davis, Melissa J. Rogers, Kelly L. Hollande, Frédéric Merino, Delphine |
author_facet | Berthelet, Jean Wimmer, Verena C. Whitfield, Holly J. Serrano, Antonin Boudier, Thomas Mangiola, Stefano Merdas, Michal El-Saafin, Farrah Baloyan, David Wilcox, Jordan Wilcox, Steven Parslow, Adam C. Papenfuss, Anthony T. Yeo, Belinda Ernst, Matthias Pal, Bhupinder Anderson, Robin L. Davis, Melissa J. Rogers, Kelly L. Hollande, Frédéric Merino, Delphine |
author_sort | Berthelet, Jean |
collection | PubMed |
description | Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor–α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment. |
format | Online Article Text |
id | pubmed-8262813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-82628132021-07-16 The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile Berthelet, Jean Wimmer, Verena C. Whitfield, Holly J. Serrano, Antonin Boudier, Thomas Mangiola, Stefano Merdas, Michal El-Saafin, Farrah Baloyan, David Wilcox, Jordan Wilcox, Steven Parslow, Adam C. Papenfuss, Anthony T. Yeo, Belinda Ernst, Matthias Pal, Bhupinder Anderson, Robin L. Davis, Melissa J. Rogers, Kelly L. Hollande, Frédéric Merino, Delphine Sci Adv Research Articles Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor–α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment. American Association for the Advancement of Science 2021-07-07 /pmc/articles/PMC8262813/ /pubmed/34233875 http://dx.doi.org/10.1126/sciadv.abf4408 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Research Articles Berthelet, Jean Wimmer, Verena C. Whitfield, Holly J. Serrano, Antonin Boudier, Thomas Mangiola, Stefano Merdas, Michal El-Saafin, Farrah Baloyan, David Wilcox, Jordan Wilcox, Steven Parslow, Adam C. Papenfuss, Anthony T. Yeo, Belinda Ernst, Matthias Pal, Bhupinder Anderson, Robin L. Davis, Melissa J. Rogers, Kelly L. Hollande, Frédéric Merino, Delphine The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile |
title | The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile |
title_full | The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile |
title_fullStr | The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile |
title_full_unstemmed | The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile |
title_short | The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile |
title_sort | site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262813/ https://www.ncbi.nlm.nih.gov/pubmed/34233875 http://dx.doi.org/10.1126/sciadv.abf4408 |
work_keys_str_mv | AT bertheletjean thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT wimmerverenac thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT whitfieldhollyj thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT serranoantonin thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT boudierthomas thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT mangiolastefano thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT merdasmichal thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT elsaafinfarrah thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT baloyandavid thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT wilcoxjordan thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT wilcoxsteven thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT parslowadamc thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT papenfussanthonyt thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT yeobelinda thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT ernstmatthias thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT palbhupinder thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT andersonrobinl thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT davismelissaj thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT rogerskellyl thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT hollandefrederic thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT merinodelphine thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT bertheletjean siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT wimmerverenac siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT whitfieldhollyj siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT serranoantonin siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT boudierthomas siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT mangiolastefano siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT merdasmichal siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT elsaafinfarrah siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT baloyandavid siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT wilcoxjordan siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT wilcoxsteven siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT parslowadamc siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT papenfussanthonyt siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT yeobelinda siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT ernstmatthias siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT palbhupinder siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT andersonrobinl siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT davismelissaj siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT rogerskellyl siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT hollandefrederic siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile AT merinodelphine siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile |